Esra Labernas Atış Appointed Finance Director at Santa Farma İlaç

Santa Farma İlaç, one of Turkey's established domestic pharmaceutical companies, has strengthened its senior management team with an experienced appointment. Esra Labernas Atış was appointed to the position of Chief Financial Officer (CFO) as of 5 February. Atış will report directly to the CEO.

Esra Labernas Atış brings 23 years of finance experience and is recognized for her expertise in financial management, budgeting and planning, financial reporting, internal controls, process improvement and strategic decision support. Her experience is expected to make a significant contribution to Santa Farma's financial strategies and sustainable growth objectives.

23-Year Finance Career
Atış is a graduate of Istanbul University's Department of English Economics and holds a Certified Public Accountant license. She began her professional career in 2003 at KPMG Audit, where she worked on various audit and IPO projects.

Transitioning to the pharmaceutical sector in 2012, Atış worked at Daiichi Sankyo Turkey until 2018 as Finance Group Manager reporting to the Country General Manager. Between 2018 and 2024, she served as Budget, Financial Reporting and Control Manager at Menarini Turkey.

Most recently serving as Finance Director for Unilever Turkey and Central Asia with financial leadership responsibilities across a broad geographic region, Atış will lead Santa Farma's financial management processes in her new role.

Santa Farma
Founded as Farma Laboratory in 1944 and merged with Santa Laboratory in 1946 to form the foundations of its present structure, Santa Farma is among the established players in Turkey's pharmaceutical sector with a history spanning over 80 years.

The company strengthened its corporate structure as Santa Farma İlaç Fabrikası Kollektif Şirketi in 1954 and as Santa Farma İlaç Sanayi A.Ş. in 1973. Today it operates with 56 brands and 127 products across 10 distinct therapeutic categories. With a product portfolio covering a broad range of therapeutic areas including dermatology, gastroenterology, infectious diseases, cardiovascular system, nervous system and respiratory system, Santa Farma conducts its manufacturing at its facility in the GEBKİM Organized Industrial Zone.